DD135445A5 - Verfahren zur herstellung eines antibiotischen mittels - Google Patents

Verfahren zur herstellung eines antibiotischen mittels

Info

Publication number
DD135445A5
DD135445A5 DD78204656A DD20465678A DD135445A5 DD 135445 A5 DD135445 A5 DD 135445A5 DD 78204656 A DD78204656 A DD 78204656A DD 20465678 A DD20465678 A DD 20465678A DD 135445 A5 DD135445 A5 DD 135445A5
Authority
DD
German Democratic Republic
Prior art keywords
producing
antibiotic agent
antibiotic
agent
Prior art date
Application number
DD78204656A
Other languages
German (de)
English (en)
Inventor
William W Armstrong
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD135445A5 publication Critical patent/DD135445A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
DD78204656A 1977-04-27 1978-04-07 Verfahren zur herstellung eines antibiotischen mittels DD135445A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/791,627 US4126680A (en) 1977-04-27 1977-04-27 Tetracycline antibiotic compositions

Publications (1)

Publication Number Publication Date
DD135445A5 true DD135445A5 (de) 1979-05-09

Family

ID=25154289

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78204656A DD135445A5 (de) 1977-04-27 1978-04-07 Verfahren zur herstellung eines antibiotischen mittels

Country Status (38)

Country Link
US (1) US4126680A (cs)
JP (1) JPS53136514A (cs)
AR (1) AR217844A1 (cs)
AT (1) AT360148B (cs)
AU (1) AU503139B1 (cs)
BE (1) BE866419A (cs)
BG (1) BG47943A3 (cs)
CA (1) CA1100875A (cs)
CH (1) CH630260A5 (cs)
CS (1) CS199527B2 (cs)
DD (1) DD135445A5 (cs)
DE (1) DE2817335C3 (cs)
DK (1) DK155977C (cs)
EG (1) EG14348A (cs)
ES (1) ES468749A1 (cs)
FI (3) FI781300A7 (cs)
FR (1) FR2388561A1 (cs)
GB (1) GB1563478A (cs)
GR (1) GR70062B (cs)
HU (1) HU179050B (cs)
IE (1) IE47049B1 (cs)
IL (1) IL54581A0 (cs)
IN (1) IN148197B (cs)
IT (1) IT1094557B (cs)
LU (1) LU79547A1 (cs)
MX (1) MX6087E (cs)
NL (1) NL7804455A (cs)
NO (1) NO148280C (cs)
NZ (1) NZ187046A (cs)
OA (1) OA05949A (cs)
PH (1) PH12962A (cs)
PL (1) PL110459B1 (cs)
PT (1) PT67895B (cs)
RO (2) RO77953A (cs)
SE (1) SE443507B (cs)
YU (1) YU87178A (cs)
ZA (1) ZA782400B (cs)
ZM (1) ZM3878A1 (cs)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US5589470A (en) * 1990-02-26 1996-12-31 Trustees Of Tufts College Reducing tetracycline resistance in living cells
US5064821A (en) * 1982-11-18 1991-11-12 Trustees Of Tufts College Method and compositions for overcoming tetracycline resistance within living cells
US4806529A (en) * 1982-11-18 1989-02-21 Trustees Of Tufts College, Tufts University Tetracycline activity enhancement
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0621033A1 (en) * 1993-04-20 1994-10-26 Nostras S.A. Antibiotic composition containing oxytetracycline and glycofurol
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
EP1240133B1 (en) 1999-09-14 2006-04-19 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
CA2397863A1 (en) 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
EP1272459B1 (en) 2000-03-31 2007-06-27 Trustees Of Tufts College 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
AU2001259701A1 (en) * 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
AU2001268475A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
CA2415172A1 (en) 2000-07-07 2002-01-17 Mark L. Nelson 13-substituted methacycline compounds
AU2001271642B2 (en) 2000-07-07 2006-01-05 Paratek Pharmaceuticals, Inc. 7-substituted tetracycline compounds
PT1301467E (pt) 2000-07-07 2006-12-29 Tufts College Compostos de minociclina 9-substituídos
DE60144375D1 (de) 2000-07-07 2011-05-19 Trustees Of Tufts College Medford 7-, 8- und 9-substitutierte tetracyclinverbindungen
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
AU2001271619B2 (en) 2001-03-13 2008-05-15 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
AU2002250331A1 (en) 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1379255A2 (en) 2001-03-14 2004-01-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
EP1399414B1 (en) 2001-04-24 2010-01-13 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2311799A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA013819B1 (ru) 2002-03-08 2010-08-30 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
WO2003079984A2 (en) 2002-03-21 2003-10-02 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2345637A3 (en) 2002-07-12 2012-02-15 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
JP2006503898A (ja) 2002-10-24 2006-02-02 パラテック ファーマシューティカルズ， インク． マラリア治療のための置換テトラサイクリン化合物
EP1656341A1 (en) 2003-07-09 2006-05-17 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050143352A1 (en) 2003-07-09 2005-06-30 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
US7786099B2 (en) * 2004-01-15 2010-08-31 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
JP2008518035A (ja) 2004-10-25 2008-05-29 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
WO2006047671A2 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
US8088755B2 (en) 2005-02-04 2012-01-03 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US9078811B2 (en) * 2006-01-24 2015-07-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CN101489987A (zh) * 2006-04-17 2009-07-22 特瓦制药工业有限公司 四环素衍生物的分离
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
CN101479235B (zh) * 2006-04-24 2013-09-18 特瓦制药工业有限公司 替加环素晶形及其制备方法
US20080118979A1 (en) * 2006-05-15 2008-05-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
ES2315123B1 (es) * 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos.
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
US8318706B2 (en) 2006-12-21 2012-11-27 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2120963B1 (en) 2006-12-21 2018-09-12 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
WO2008118744A1 (en) * 2007-03-23 2008-10-02 Molecular Research Center, Inc. Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
AU2012230089B2 (en) * 2007-03-23 2013-11-21 Molecular Research Center, Inc. Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
AU2008239606A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
ES2386926T3 (es) 2007-07-06 2012-09-06 Paratek Pharmaceuticals, Inc. Métodos para sintetizar minociclina9-sustituida
EP2262754A4 (en) 2008-03-05 2012-03-14 Paratek Pharm Innc MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
AU2009236631A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202332671A (zh) 2008-05-19 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
EA201170425A1 (ru) * 2008-09-19 2011-10-31 Паратек Фармасьютикалс, Инк. Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
WO2010118435A2 (en) 2009-04-10 2010-10-14 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
HRP20191295T8 (hr) 2011-05-12 2020-02-07 Paratek Pharmaceuticals, Inc. Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
EP2805732B1 (en) * 2013-05-20 2016-09-28 Fundación Comunidad Valenciana Centro de Investigación Principe Felipe Polymer-drug conjugates for the treatment of amyloidosis
JP6793715B2 (ja) 2015-03-23 2020-12-02 バイオファーミクス・インコーポレイテッドＢｉｏＰｈａｒｍＸ， Ｉｎｃ． テトラサイクリンの皮膚用医薬組成物
BR112019008897A2 (pt) 2016-11-01 2019-08-13 Paratek Pharm Innc método para tratar pneumonia bacteriana adquirida na comunidade.
AU2018303807B2 (en) 2017-07-21 2023-08-24 Almirall, Llc Treatment of non-inflammatory lesions
CN113655052B (zh) * 2021-08-03 2023-12-12 哈尔滨工程大学 基于高活性MgO对四环素类抗生素可视化检测的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1913323A (en) * 1931-02-28 1933-06-06 Hoffmann La Roche Stable concentrated solution for therapeutic purposes
DE647766C (de) * 1931-03-01 1937-07-12 Hoffmanni La Roche & Co Akt Ge Verfahren zur Darstellung haltbarer, konzentrierter, waessriger Loesungen der Cinchonaalkaloide
GB381012A (en) * 1931-12-04 1932-09-29 Andrew Home Morton Process for the manufacture of stable concentrated solutions for therapeutic use
DE662812C (de) * 1931-12-08 1938-07-22 Hoffmanni La Roche & Co Akt Ge Verfahren zur Herstellung haltbarer, waessriger Arzneimittelloesungen
DE673500C (de) * 1933-01-15 1939-03-23 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung von haltbaren Loesungen schwer loeslicher Arzneimittel
GB1019164A (en) * 1963-01-30 1966-02-02 Chugai Pharmaceutical Co Ltd Hemostatic preparation for injection and process for the production thereof
DK129969B (da) * 1973-01-11 1974-12-09 Rosco Ak Fremgangsmåde til fremstilling af en klar, stabil, i det væsentlige vandig opløsning af oxytetracyclin.
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions

Also Published As

Publication number Publication date
BE866419A (fr) 1978-10-26
GB1563478A (en) 1980-03-26
PT67895A (en) 1978-05-01
NO148280B (no) 1983-06-06
IN148197B (cs) 1980-11-29
NO148280C (no) 1983-09-21
FI801197A7 (fi) 1981-01-01
DK155977C (da) 1989-10-30
AR217844A1 (es) 1980-04-30
SE443507B (sv) 1986-03-03
PL110459B1 (en) 1980-07-31
ES468749A1 (es) 1979-01-01
DE2817335B2 (de) 1981-06-11
AU503139B1 (en) 1979-08-23
IE780828L (en) 1978-10-27
CA1100875A (en) 1981-05-12
MX6087E (es) 1984-11-08
IE47049B1 (en) 1983-12-14
PH12962A (en) 1979-10-19
SE7801816L (sv) 1978-10-28
EG14348A (en) 1984-09-30
ATA300478A (de) 1980-05-15
FI801196A7 (fi) 1981-01-01
FI781300A7 (fi) 1978-10-28
CH630260A5 (fr) 1982-06-15
NL7804455A (nl) 1978-10-31
HU179050B (en) 1982-08-28
RO75099A (ro) 1980-12-30
AT360148B (de) 1980-12-29
YU87178A (en) 1984-04-30
DK155977B (da) 1989-06-12
CS199527B2 (en) 1980-07-31
IT1094557B (it) 1985-08-02
BG47943A3 (bg) 1990-10-15
DE2817335A1 (de) 1978-11-16
US4126680A (en) 1978-11-21
FR2388561A1 (fr) 1978-11-24
ZM3878A1 (en) 1978-11-21
NZ187046A (en) 1980-03-05
JPS53136514A (en) 1978-11-29
OA05949A (fr) 1981-06-30
DK182578A (da) 1978-10-28
NO781457L (no) 1978-10-30
IT7822720A0 (it) 1978-04-26
RO77953A (ro) 1981-12-25
GR70062B (cs) 1982-07-26
IL54581A0 (en) 1978-07-31
ZA782400B (en) 1979-04-25
PT67895B (en) 1979-11-14
LU79547A1 (fr) 1979-11-07
JPS5632290B2 (cs) 1981-07-27
DE2817335C3 (de) 1982-04-22
PL206050A1 (pl) 1979-03-26
FR2388561B1 (cs) 1980-07-18

Similar Documents

Publication Publication Date Title
DD135445A5 (de) Verfahren zur herstellung eines antibiotischen mittels
AT355947B (de) Verfahren zur herstellung eines oxydischen schleifmittels
AT362082B (de) Verfahren zur herstellung eines desinfektions- mittels
LU79519A1 (de) Verfahren zur herstellung eines wachstumsfoerdernden mittels
AT351503B (de) Verfahren zur herstellung eines alkylaromatischen kohlenwasserstoffes, vorzugs- weise cumol
DD133632A5 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss-praeparates
AT365657B (de) Verfahren zur herstellung eines extra harten materials
AT367066B (de) Verfahren zur herstellung eines selektiv geschuetzten n-acylierten derivates eines aminoglycosid-antibiotikums
AT347577B (de) Verfahren zur herstellung eines antiviralen mittels
ATA268678A (de) Verfahren zur herstellung eines isomalto-oligo- saccaridgemisches
ATA449178A (de) Verfahren zur herstellung eines keramischen gegenstandes
AT371089B (de) Verfahren zur herstellung eines keramischen schaumstoffes
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
DD134079A5 (de) Verfahren zur herstellung eines baukoerpers
AT361618B (de) Verfahren zur herstellung einer antibiotischen mischung
AT362491B (de) Verfahren zur herstellung eines antidepressiv wirksamen pharmazeutischen praeparates
DD131225A1 (de) Verfahren zur herstellung eines festen zahnpflegemittels
DD138222A5 (de) Verfahren zur herstellung eines antibiotikums
DD132404A1 (de) Verfahren zur herstellung eines arzneimitteltraegers
DD130657A5 (de) Verfahren zur herstellung eines azetamid-derivates
DE3484446D1 (de) Verfahren zur herstellung eines inhibitorischen mittels.
ATA598378A (de) Verfahren zur herstellung eines pharma- zeutischen blutstillenden mittels
AT365928B (de) Verfahren zur herstellung eines antaziden pharmazeutischen mittels
AT357174B (de) Verfahren zur herstellung eines asbestdia- phragmas
DD133056A1 (de) Verfahren zur herstellung eines antibiotikums